Abvc Biopharma

ABVCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$30.653 M

$1.15 -0.86%

Close of 21 Sept 2026

Revenue

$509.6K

#3533 by revenue

Earnings

-$7.91M

Loss-making

Shares outstanding

26,654,365

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#373Rockwell MedicalRMTI$35.1M
#374Context TherapeuticsCNTX$34.4M
#375Abvc BiopharmaABVC$30.7M
#376BeyondSpringBYSI$30.4M
#377Transcode TherapeuticsRNAZ$29.8M

What if Abvc Biopharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,135,801

Per share 987,653× higher

Bitcoin $1.72T

$64,522.40

Per share 56,106× higher

Nvidia $5.48T

$205,589.51

Per share 178,773× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Abvc Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.